Thermo-sensitive gel in glaucoma therapy for enhanced bioavailability: In vitro characterization, in vivo pharmacokinetics and pharmacodynamics study
- PMID: 30268857
- DOI: 10.1016/j.lfs.2018.09.050
Thermo-sensitive gel in glaucoma therapy for enhanced bioavailability: In vitro characterization, in vivo pharmacokinetics and pharmacodynamics study
Abstract
Aims: Glaucoma is a chronic ophthalmic disease, which has become one of the leading causes to progressive and irreversible blindness. Current ophthalmic drug delivery to treat glaucoma is mostly eyedrop, whose rapid elimination on corneal surface can lead to poor bioavailability. The present study was aimed to develop a timolol maleate loaded thermo-sensitive gel (TM-TSG) with improved bioavailability to treat glaucoma.
Main methods: TM-TSG was prepared by homogeneously dispersing 0.3% (w/v) timolol maleate, 24.25% (w/v) poloxamer 407 (P407) and 1.56% (w/v) poloxamer 188 (P188) into phosphate buffer solution (pH = 7.4) and the formulated TM-TSG was characterized.
Key findings: TM-TSG was stored in liquid form at room temperature (25 °C) and transited to semisolid gel at physiological temperature (32 °C). The rheological property of TM-TSG was in favor of uniform distribution of drug. TM-TSG showed good stability at different conditions including centrifugation, autoclaving and different temperature. In vivo pharmacokinetic studies indicated that TM-TSG could enhance absorption of TM in aqueous humor and improve the ocular bioavailability in comparison of commercial TM eyedrops. In vivo experiment result showed that TM-TSG had greater effect in treating glaucoma than TM eyedrops by sustainably lowering intraocular pressure (IOP) for a week. Moreover, slit lamp test and histopathological analysis demonstrated that TM-TSG had excellent biocompatibility.
Significance: TM-TSG could be a promising ophthalmic delivery system for glaucoma therapy.
Keywords: Glaucoma; Pharmacokinetics; Thermo-sensitive gel; Timolol maleate.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Pharmacokinetics and intraocular pressure lowering effect of timolol preparations in rabbit eyes.J Ocul Pharmacol Ther. 1996 Winter;12(4):471-80. doi: 10.1089/jop.1996.12.471. J Ocul Pharmacol Ther. 1996. PMID: 8951683
-
Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation.AAPS PharmSciTech. 2017 Nov;18(8):2919-2926. doi: 10.1208/s12249-017-0763-8. Epub 2017 Apr 20. AAPS PharmSciTech. 2017. PMID: 28429294
-
The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case.Eur J Pharm Sci. 2017 Jul 15;105:188-194. doi: 10.1016/j.ejps.2017.05.020. Epub 2017 May 12. Eur J Pharm Sci. 2017. PMID: 28506871
-
Medical management of glaucoma: focus on ophthalmologic drug delivery systems of timolol maleate.Artif Cells Nanomed Biotechnol. 2017 May;45(3):448-459. doi: 10.3109/21691401.2016.1160917. Epub 2016 Mar 22. Artif Cells Nanomed Biotechnol. 2017. PMID: 27002850 Review.
-
Timolol hemihydrate: a new formulation of timolol for the treatment of glaucoma.J Ocul Pharmacol Ther. 1996 Summer;12(2):225-37. doi: 10.1089/jop.1996.12.225. J Ocul Pharmacol Ther. 1996. PMID: 8773937 Review.
Cited by
-
Dendrimer and dendrimer gel-derived drug delivery systems: Breaking bottlenecks of topical administration of glaucoma medications.MedComm Biomater Appl. 2023 Mar;2(1):e30. doi: 10.1002/mba2.30. Epub 2023 Feb 20. MedComm Biomater Appl. 2023. PMID: 38562247 Free PMC article.
-
Breaking Barriers in Eye Treatment: Polymeric Nano-Based Drug-Delivery System for Anterior Segment Diseases and Glaucoma.Polymers (Basel). 2023 Mar 9;15(6):1373. doi: 10.3390/polym15061373. Polymers (Basel). 2023. PMID: 36987154 Free PMC article. Review.
-
Cubic and hexagonal liquid crystal gels for ocular delivery with enhanced effect of pilocarpine nitrate on anti-glaucoma treatment.Drug Deliv. 2019 Dec;26(1):952-964. doi: 10.1080/10717544.2019.1667451. Drug Deliv. 2019. PMID: 31544551 Free PMC article.
-
PLGA microsphere-based composite hydrogel for dual delivery of ciprofloxacin and ginsenoside Rh2 to treat Staphylococcus aureus-induced skin infections.Drug Deliv. 2020 Dec;27(1):632-641. doi: 10.1080/10717544.2020.1756985. Drug Deliv. 2020. PMID: 32329376 Free PMC article.
-
A long-term retaining molecular coating for corneal regeneration.Bioact Mater. 2021 May 5;6(12):4447-4454. doi: 10.1016/j.bioactmat.2021.04.032. eCollection 2021 Dec. Bioact Mater. 2021. PMID: 33997518 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous